[1]
|
Weinberg, R.A. (2006) The Biologу of Cancer. Garland Science, New York, 796 p.
|
[2]
|
Kushlinskii, N.E. and Nemtsova, M.V. (2014) Molecular Biological Characteristics of Cancer. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, 1-2, 5-15.
|
[3]
|
Bizzarri, M. and Cucina, A. (2014) Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis? BioMed Research International, 2014, Article ID: 934038. http://dx.doi.org/10.1155/2014/934038
|
[4]
|
Herbst, R.S., Bajorin, D.F., Bleiberg, H., Blum, D., Hao, D., Johnson, B.E., et al. (2006) Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report from the American Society of Clinical Oncology. Journal of Clinical Oncology, 24, 190-205. http://dx.doi.org/10.1200/JCO.2005.04.8678
|
[5]
|
Stewart, B.W. and Wild, C.P. (2014) World Cancer Report 2014. IARC Nonserial Publication (WHO), 630 p.
|
[6]
|
Pitot, H.C. and Dragan, Y.P. (1991) Facts and Theories Concerning the Mechanisms of Carcinogenesis. The FASEB Journal, 5, 2280-2286.
|
[7]
|
Halazonetis, T.D., Gorgoulis, V.G. and Bartek, J. (2008) An Oncogene-Induced DNA Damage Model for Cancer Development. Science, 319, 1352-1355. http://dx.doi.org/10.1126/science.1140735
|
[8]
|
Collisson, E.A., Cho, R.J. and Gray, J.W. (2012) What Are We Learning from the Cancer Genome? Nature Reviews Clinical Oncology, 9, 621-630. http://dx.doi.org/10.1038/nrclinonc.2012.159
|
[9]
|
Das, S.K., Menezes, M.E., Bhatia, S., Wang, X.Y., Emdad, L., Sarkar, D. and Fisher, P.B. (2015) Gene Therapies for Cancer: Strategies, Challenges and Successes. Journal of Cellular Physiology, 230, 259-271. http://dx.doi.org/10.1002/jcp.24791
|
[10]
|
Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a Key Event in Cancer Development. Molecular Cancer Research, 4, 221-233. http://dx.doi.org/10.1158/1541-7786.MCR-05-0261
|
[11]
|
Prendergast, G.C. and Jaffee, E.M. (2007) Cancer Immunologists and Cancer Biologists: Why We Didn’t Talk Then but Need to Now. Cancer Research, 67, 3500-3504. http://dx.doi.org/10.1158/0008-5472.CAN-06-4626
|
[12]
|
Poggi, A. and Zocchi, M.R. (2006) Mechanisms of Tumor Escape: Role of Tumor Microenvironment in Inducing Apoptosis of Cytolytic Effector Cells. Archivum Immunologiae et Therapiae Experimentalis (Warszawa), 54, 323-333. http://dx.doi.org/10.1007/s00005-006-0038-7
|
[13]
|
Burkholder, B., Huang, R.Y., Burgess, R., Luo, S., Jones, V.S., Zhang, W., et al. (2014) Tumor-Induced Perturbations of Cytokines and Immune Cell Networks. Biochimica et Biophysica Acta, 1845, 182-201. http://dx.doi.org/10.1016/j.bbcan.2014.01.004
|
[14]
|
Vona-Davis, L. and Rose, D.P. (2007) Adipokines as Endocrine, Paracrine, and Autocrine Factors in Breast Cancer Risk and Progression. Endocrine Related Cancer, 14, 189-206. http://dx.doi.org/10.1677/ERC-06-0068
|
[15]
|
Baccelli, I. and Trumpp, A. (2012) The Evolving Concept of Cancer and Metastasis Stem Cells. Journal of Cell Biology, 198, 281-293. http://dx.doi.org/10.1083/jcb.201202014
|
[16]
|
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A.P. and Bellet, D. (2007) Molecular Circuits Shared by Placental and Cancer Cells, and Their Implications in the Proliferative, Invasive and Migratory Capacities of Trophoblasts. Human Reproduction Update, 13,121-141. http://dx.doi.org/10.1093/humupd/dml048
|
[17]
|
Reuter, S., Gupta, S.C., Chaturvedi, M.M. and Aggarwal, B.B. (2010) Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radical Biology and Medicine, 49, 1603-1616. http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.006
|
[18]
|
Toyokuni, S., Okamoto, K., Yodoi, J. and Hiai, H. (1995) Persistent Oxidative Stress in Cancer. FEBS Letters, 358, 1-3. http://dx.doi.org/10.1016/0014-5793(94)01368-B
|
[19]
|
Crawford, S. (2014) Anti-Inflammatory/Antioxidant Use in Long-Term Maintenance Cancer Therapy: A New Therapeutic Approach to Disease Progression and Recurrence. Therapeutic Advances in Medical Oncology, 6, 52-68. http://dx.doi.org/10.1177/1758834014521111
|
[20]
|
Ng, S. and Galipeau, J. (2015) Concise Review: Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders. Stem Cells Translational Medicine, 4, 66-73. http://dx.doi.org/10.5966/sctm.2014-0145
|
[21]
|
Ascierto, P.A., Addeo, R., Carteni, G., Daniele, B., De Laurentis, M., Ianniello, G., et al. (2014) The Role of Immunotherapy in Solid Tumors: Report from the Campania Society of Oncology Immunotherapy (SCITO) Meeting, Naples 2014. Journal of Translational Medicine, 12, 291. http://www.translational-medicine.com/content/12/1/291 http://dx.doi.org/10.1186/s12967-014-0291-1
|
[22]
|
Kenderian, S.S., Ruella, M., Gill, S. and Kalos, M. (2014) Chimeric Antigen Receptor T-Cell Therapy to Target Hematologic Malignancies. Cancer Research, 74, 6383-6389. http://dx.doi.org/10.1158/0008-5472.CAN-14-1530
|
[23]
|
Westwood, J.A. and Kershaw, M.H. (2010) Genetic Redirection of T Cells for Cancer Therapy. Journal of Leukocyte Biology, 87, 791-803. http://dx.doi.org/10.1189/jlb.1209824
|
[24]
|
Pol, J., Bloy, N., Obrist, F., Eggermont, A., Galon, J., Hervé Fridman, W., et al. (2014) Trial Watch: DNA Vaccines for Cancer Therapy. Oncoimmunology, 3, Article ID: e28185. http://dx.doi.org/10.4161/onci.23803
|
[25]
|
Huang, Y., Goel, S., Duda, D.G., Fukumura, D. and Jain, R.K. (2013) Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy. Cancer Research, 73, 2943-2948. http://dx.doi.org/10.1158/0008-5472.CAN-12-4354
|
[26]
|
Jacobs, J.J., Snackey, C., Geldof, A.A., Characiejus, D., Van Moorselaar, R.J. and Den Otter, W. (2014) Inefficacy of Therapeutic Cancer Vaccines and Proposed Improvements. Casus of Prostate Cancer. Anticancer Research, 34, 2689-2700.
|
[27]
|
Mosser, D.M. and Edwards, J.P. (2008) Exploring the Full Spectrum of Macrophage Activation. Nature Reviews Immunology, 8, 958-969. http://dx.doi.org/10.1038/nri2448
|
[28]
|
Martinez, F.O. and Gordon, S. (2014) The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment. F1000Prime Reports, 6, 13. http://dx.doi.org/10.12703/P6-13
|
[29]
|
Barbul, A., Breslin, R.J., Woodyard, J.P., Wasserkrug, H.L. and Efron, G. (1989) The Effect of in Vivo T Helper and T Suppressor Lymphocyte Depletion on Wound Healing. Annals of Surgery, 209, 479-483. http://dx.doi.org/10.1097/00000658-198904000-00015
|
[30]
|
Erenpreiss, J. (1993) Current Concepts of Malignant Growth. Part A: From a Normal Cell to Cancer. Zvaigzne Publishers, Riga, 191 p.
|
[31]
|
Boyce, D.E., Jones, W.D., Ruge, F., Harding, K.G. and Moore, K. (2000) The Role of Lymphocytes in Human Dermal Wound Healing. British Journal of Dermatology, 143, 59-65. http://dx.doi.org/10.1046/j.1365-2133.2000.03591.x
|
[32]
|
Ishida, Y., Kondo, T., Takayasu, T., Iwakura, Y. and Mukaida, N. (2004) The Essential Involvement of Cross-Talk Between IFN-γ and TGF-β in the Skin Wound Healing Process. Journal of Immunology, 172, 1848-1855. http://dx.doi.org/10.4049/jimmunol.172.3.1848
|
[33]
|
Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, Y., Lee, V.W., et al. (2010) IL-10/TGF-Beta-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis. Journal of the American Society of Nephrology, 21, 933-942. http://dx.doi.org/10.1681/ASN.2009060592
|
[34]
|
Duffield, J.S. (2003) The Inflammatory Macrophage: A Story of Jekyll and Hyde. Clinical Science, 104, 27-38. http://dx.doi.org/10.1042/CS20020240
|
[35]
|
Eming, S.A., Krieg, T. and Davidson, J.M. (2007) Inflammation in Wound Repair: Molecular and Cellular Mechanisms. Journal of Investigative Dermatology, 127, 514-525. http://dx.doi.org/10.1038/sj.jid.5700701
|
[36]
|
Traversa, B. and Sussman, G. (2001) The Role of Growth Factors, Cytokines and Proteases in Wound Management. Primary Intention: The Australian Journal of Wound Management, 9, 161-167.
|
[37]
|
Gratchev, A., Schledzewski, K., Guillot, P. and Goerdt, S. (2001) Alternatively Activated Antigen-Presenting Cells: Molecular Repertoire, Immune Regulation, and Healing. Skin Pharmacology and Applied Skin Physiology, 14, 272-279. http://dx.doi.org/10.1159/000056357
|
[38]
|
Smith, C., Kruger, M.J., Smith, R.M. and Myburgh, K.H. (2008) The Inflammatory Response to Skeletal Muscle Injury: Illuminating Complexities. Sports Medicine, 38, 947-969. http://dx.doi.org/10.2165/00007256-200838110-00005
|
[39]
|
Lewis, C.J., Mardaryev, A.N., Sharov, A.A., Fessing, M.Y. and Botchkarev, V.A. (2014) The Epigenetic Regulation of Wound Healing. Advances in Wound Care (New Rochelle), 3, 468-475. http://dx.doi.org/10.1089/wound.2014.0522
|
[40]
|
Agaiby, A.D. and Dyson, M. (1999) Immuno-Inflammatory Cell Dynamics during Cutaneous Wound Healing. Journal of Anatomy, 195, 531-542. http://dx.doi.org/10.1046/j.1469-7580.1999.19540531.x
|
[41]
|
Gordon, S. and Martinez, F.O. (2010) Alternative Activation of Macrophages: Mechanism and Functions. Immunity, 32, 593-604. http://dx.doi.org/10.1016/j.immuni.2010.05.007
|
[42]
|
Lech, M., Grobmayr, R., Weidenbusch, M. and Anders, H-J. (2012) Tissues Use Resident Dendritic Cells and Macrophages to Maintain Homeostasis and to Regain Homeostasis upon Tissue Injury: The Immunoregulatory Role of Changing Tissue Environments. Mediators of Inflammation, 2012, Article ID: 951390. http://dx.doi.org/10.1155/2012/951390
|
[43]
|
Ghiringhelli, F., Ménard, C., Martin, F. and Zitvogel, L. (2006) The Role of Regulatory T Cells in the Control of Natural Killer Cells: Relevance during Tumor Progression. Immunological Reviews, 214, 229-238. http://dx.doi.org/10.1111/j.1600-065X.2006.00445.x
|
[44]
|
Radosavljevic, G.D., Jovanovic, I.P., Kanjevac, T.V. and Arsenijevic, N.N. (2013) The Role of Regulatory T Cells in the Modulation of Anti-Tumor Immune Response. Srpski arhiv za celokupno lekarstvo (Serbian), 141, 262-267. http://dx.doi.org/10.2298/SARH1304262R
|
[45]
|
Bruno, A., Ferlazzo, G., Albini, A. and Noonan, D.M. (2014) A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis. Journal of the National Cancer Institute, 106, dju200. http://www.ncbi.nlm.nih.gov/pubmed/25178695 http://dx.doi.org/10.1093/jnci/dju200
|
[46]
|
Sloan, E.K., Priceman, S.J., Cox, B.F., Yu, S., Pimentel, M.A., Tangkanangnukul, V., et al. (2010) The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer. Cancer Research, 70, 7042-7052. http://dx.doi.org/10.1158/0008-5472.CAN-10-0522
|
[47]
|
J?rgensen, A. (2013) Oxidatively Generated DNA/RNA Damage in Psychological Stress States. Danish Medical Journal, 60, Article ID: B4685. http://www.ncbi.nlm.nih.gov/pubmed/23809980
|
[48]
|
Aschbacher, K., O’Donovan, A., Wolkowitz, O.M., Dhabhar, F.S., Su, Y. and Epel, E. (2013) Good Stress, Bad Stress and Oxidative Stress: Insights from Anticipatory Cortisol Reactivity. Psychoneuroendocrinology, 38, 1698-1708. http://dx.doi.org/10.1016/j.psyneuen.2013.02.004
|
[49]
|
Flint, M.S. and Bovbjerg, D.H. (2012) DNA Damage as a Result of Psychological Stress: Implications for Breast Cancer. Breast Cancer Research, 14, 320. http://www.ncbi.nlm.nih.gov/pubmed/23490070 http://dx.doi.org/10.1186/bcr3189
|
[50]
|
Bukhtoyarov, O.V. and Samarin, D.M. (2009) Psychogenic Carcinogenesis: Carcinogenesis without Exogenic Carcinogens. Medical Hypotheses, 73, 531-536. http://dx.doi.org/10.1016/j.mehy.2009.06.004
|
[51]
|
Bartsch, H. and Nair, J. (2006) Chronic Inflammation and Oxidative Stress in the Genesis and Perpetuation of Cancer: Role of Lipid Peroxidation, DNA Damage, and Repair. Langenbeck’s Archives Surgery, 391, 499-510. http://dx.doi.org/10.1007/s00423-006-0073-1
|
[52]
|
Mantovani, A. (2010) Molecular Pathways Liking Inflammation and Cancer. Current Molecular Medicine, 10, 369-373. http://dx.doi.org/10.2174/156652410791316968
|
[53]
|
Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, Inflammation, and Cancer. Cell, 140, 883-899. http://dx.doi.org/10.1016/j.cell.2010.01.025
|
[54]
|
Vaziri, H. and Benchimol, S. (1996) From Telomere Loss to p53 Induction and Activation of a DNA-Damage Pathway at Senescence: The Telomere Loss/DNA Damage Model of Cell Aging. Experimental Gerontology, 31, 295-301. http://dx.doi.org/10.1016/0531-5565(95)02025-X
|
[55]
|
Shimizu, I., Yoshida, Y., Suda, M. and Minamino, T. (2014) DNA Damage Response and Metabolic Disease. Cell Metabolism, 20, 967-977. http://dx.doi.org/10.1016/j.cmet.2014.10.008
|
[56]
|
Huang, J., Xie, Y., Sun, X., Zeh, H.J., Kang, R., Lotze, M.T. and Tang, D. (2014) DAMPs, Ageing, and Cancer: The “DAMP Hypothesis”. Ageing Research Reviews, 14, S1568-S1637. http://www.ncbi.nlm.nih.gov/pubmed/25446804 http://dx.doi.org/10.1016/j.arr.2014.10.004
|
[57]
|
Franceschi, C. and Campisi, J. (2014) Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 69, S4-S9. http://www.ncbi.nlm.nih.gov/pubmed/24833586 http://dx.doi.org/10.1093/gerona/glu057
|
[58]
|
Riggs, J.W., Barrilleaux, B.L., Varlakhanova, N., Bush, K.M., Chan, V. and Knoepfler, P.S. (2013) Induced Pluripotency and Oncogenic Transformation Are Related Processes. Stem Cells, 22, 37-50. http://dx.doi.org/10.1089/scd.2012.0375
|
[59]
|
Upadhyay, M., Samal, J., Kandpal, M., Singh, O.V. and Vivekanandan, P. (2013) The Warburg Effect: Insights from the Past Decade. Pharmacology & Therapeutics, 137, 318-330. http://dx.doi.org/10.1016/j.pharmthera.2012.11.003
|
[60]
|
Razungles, J., Cavaillès, V., Jalaguier, S. and Teyssier, C. (2013) The Warburg Effect: From Theory to Therapeutic Applications in Cancer. Médecine sciences (Paris), 29, 1026-1033. http://www.ncbi.nlm.nih.gov/pubmed/24280507 http://dx.doi.org/10.1051/medsci/20132911020
|
[61]
|
Ito, K. and Suda, T. (2014) Metabolic Requirements for the Maintenance of Self-Renewing Stem Cells. Nature Reviews Molecular Cell Biology, 15, 243-256. http://dx.doi.org/10.1038/nrm3772
|
[62]
|
Lee, K.E. and Simon, M.C. (2012) From Stem Cells to Cancer Stem Cells: HIF Takes the Stage. Current Opinion in Cell Biology, 24, 232-235. http://dx.doi.org/10.1016/j.ceb.2012.01.005
|
[63]
|
Natarajan, T.G., Ganesan, N. and Fitzgerald, K.T. (2010) Cancer Stem Cells and Markers: New Model of Tumorigenesis with Therapeutic Implications. Cancer Biomarkers, 9, 65-99.
|
[64]
|
Glenn, J.D. and Whartenby, K.A. (2014) Mesenchymal Stem Cells: Emerging Mechanisms of Immunomodulation and Therapy. World Journal of Stem Cells, 6, 526-539. http://dx.doi.org/10.4252/wjsc.v6.i5.526
|
[65]
|
Ivanovic, Z. (2009) Hypoxia or in Situ Normoxia: The Stem Cell Paradigm. Journal of Cellular Physiology, 219, 271-275. http://dx.doi.org/10.1002/jcp.21690
|
[66]
|
Riazi, A.M., Kwon, S.Y. and Stanford, W.L. (2009) Stem Cell Sources for Regenerative Medicine. Methods in Molecular Biology, 482, 55-90. http://dx.doi.org/10.1007/978-1-59745-060-7_5
|
[67]
|
Lane, S.W., Williams, D.A. and Watt, F.M. (2014) Modulating the Stem Cell Niche for Tissue Regeneration. Nature Biotechnology, 32, 795-803. http://dx.doi.org/10.1038/nbt.2978
|
[68]
|
Sell, S. (2004) Stem Cell Origin of Cancer and Differentiation Therapy. Critical Reviews in Oncology/Hematology, 51, 1-28. http://dx.doi.org/10.1016/j.critrevonc.2004.04.007
|
[69]
|
Koukourakis, M.I., Giatromanolaki, A., Bougioukas, G. and Sivridis, E. (2007) Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma. Cancer Biology and Therapy, 6, 1476-1479.
|
[70]
|
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A.K., Frank, P.G., et al. (2009) The Reverse Warburg Effect: Aerobic Glycolysis in Cancer Associated Fibroblasts and the Tumor Stroma. Cell Cycle, 8, 3984-4001. http://dx.doi.org/10.4161/cc.8.23.10238
|
[71]
|
Kasai, T., Chen, L., Mizutani, A., Kudoh, T., Murakami, H., Fu, L. and Seno, M. (2014) Cancer Stem Cells Converted from Pluripotent Stem Cells and the Cancerous Niche. Journal of Stem Cells and Regenerative Medicine, 10, 2-7.
|
[72]
|
Huggins, C. (1967) Endocrine-Induced Regression of Cancers. Science, 156, 1050-1054. http://dx.doi.org/10.1126/science.156.3778.1050
|
[73]
|
McCullough, K.D., Coleman, W.B., Smith, G.J. and Grisham, J.W. (1997) Age-Dependent Induction of Hepatic Tumor Regression by the Tissue Microenvironment after Transplantation of Neoplastically Transformed Rat Liver Epithelial Cells into the Liver. Cancer Research, 57, 1807-1813.
|
[74]
|
Maffini, M.V., Calabro, J.M., Soto, A.M. and Sonnenschein, C. (2005) Stromal Regulation of Neoplastic Development: Age-Dependent Normalization of Neoplastic Mammary Cells by Mammary Stroma. American Journal of Pathology, 167, 1405-1410. http://dx.doi.org/10.1016/S0002-9440(10)61227-8
|
[75]
|
Folkman, J. and Kalluri, R. (2004) Cancer without Disease. Nature, 427, 787. http://dx.doi.org/10.1038/427787a
|
[76]
|
Aguirre-Ghiso, J.A. (2007) Models, Mechanisms and Clinical Evidence for Cancer Dormancy. Nature Reviews Cancer, 7, 834-846. http://dx.doi.org/10.1038/nrc2256
|
[77]
|
Sosa, M.S., Bragado, P. and Aguirre-Ghiso, J.A. (2014) Mechanisms of Disseminated Cancer Cell Dormancy: An Awakening Field. Nature Reviews Cancer, 14, 611-622. http://dx.doi.org/10.1038/nrc3793
|
[78]
|
Manjili, M.H. (2014) The Inherent Premise of Immunotherapy for Cancer Dormancy. Cancer Research, 74, 1-5. http://dx.doi.org/10.1158/0008-5472.CAN-14-2440
|
[79]
|
Chambers, A.F., Groom, A.C. and MacDonald, I.C. (2002) Dissemination and Growth of Cancer Cells in Metastatic Sites. Nature Reviews Cancer, 2, 563-572. http://dx.doi.org/10.1038/nrc865
|
[80]
|
Mehlen, P. and Puisieux, A. (2006) Metastasis: A Question of Life or Death. Nature Reviews Cancer, 6, 449-458. http://dx.doi.org/10.1038/nrc1886
|
[81]
|
Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L., Chambers, A.F. and Groom, A.C. (1998) Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases. American Journal of Pathology, 153, 865-873. http://dx.doi.org/10.1016/S0002-9440(10)65628-3
|
[82]
|
Kleffel, S. and Schatton, T. (2013) Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin? Advances in Experimental Medicine and Biology, 734, 145-179. http://dx.doi.org/10.1007/978-1-4614-1445-2_8
|
[83]
|
El Saghir, N.S., Elhajj, I.I., Geara, F.B. and Hourani, M.H. (2005) Trauma-Associated Growth of Suspected Dormant Micrometastasis. BMC Cancer, 5, 94. http://dx.doi.org/10.1186/1471-2407-5-94
|
[84]
|
Demicheli, R., Retsky, M.W., Hrushesky, W.J. and Baum, M. (2007) Tumor Dormancy and Surgery-Driven Interruption of Dormancy in Breast Cancer: Learning from Failures. Nature Clinical Practice Oncology, 4, 699-710. http://dx.doi.org/10.1038/ncponc0999
|
[85]
|
Mocellin, S. and Nitti, D. (2008) Therapeutics Targeting Tumor Immune Escape: Towards the Development of New Generation Anticancer Vaccines. Medicinal Research Reviews, 28, 413-444. http://dx.doi.org/10.1002/med.20110
|
[86]
|
Mittal, D., Gubin, M.M., Schreiber, R.D. and Smyth, M.J. (2014) New Insights into Cancer Immunoediting and Its Three Component Phases—Elimination, Equilibrium and Escape. Current Opinion in Immunology, 27, 16-25. http://dx.doi.org/10.1016/j.coi.2014.01.004
|
[87]
|
Corthay, A. (2014) Does the Immune System Naturally Protect Against Cancer? Frontiers in Immunology, 5, 197. http://dx.doi.org/10.3389/fimmu.2014.00197
|
[88]
|
Gajewski, T.F., Woo, S.R., Zha, Y., Spaapen, R., Zheng, Y., Corrales, L. and Spranger, S. (2013) Cancer Immunotherapy Strategies Based on Overcoming Barriers within the Tumor Microenvironment. Current Opinion in Immunology, 25, 268-276. http://dx.doi.org/10.1016/j.coi.2013.02.009
|
[89]
|
Yi, D.H. and Appel, S. (2013) Current Status and Future Perspectives of Dendritic Cell-Based Cancer Immunotherapy. Scandinavian Journal of Immunology, 78, 167-171. http://dx.doi.org/10.1111/sji.12060
|
[90]
|
Mougiakakos, D., Choudhury, A., Lladser, A., Kiessling, R. and Johansson, C.C. (2010) Regulatory T Cells in Cancer. Advances in Cancer Research, 107, 57-117. http://dx.doi.org/10.1016/S0065-230X(10)07003-X
|
[91]
|
Oleinika, K., Nibbs, R.J., Graham, G.J. and Fraser, A.R. (2013) Suppression, Subversion and Escape: The Role of Regulatory T Cells in Cancer Progression. Clinical and Experimental Immunology, 171, 36-45. http://dx.doi.org/10.1111/j.1365-2249.2012.04657.x
|
[92]
|
López, M., Aguilera, R., Pérez, C., Mendoza-Naranjo, A., Pereda, C., Ramirez, M., et al. (2006) The Role of Regulatory T Lymphocytes in the Induced Immune Response Mediated by Biological Vaccines. Immunobiology, 211, 127-136. http://dx.doi.org/10.1016/j.imbio.2005.11.003
|
[93]
|
Song, S., Zhang, K., You, H., Wang, J., Wang, Z., Yan, C. and Liu, F. (2010) Significant Anti-Tumour Activity of Adoptively Transferred T Cells Elicited by Intratumoral Dendritic Cell Vaccine Injection through Enhancing the Ratio of CD8+ T Cell/Regulatory T Cells in Tumour. Clinical and Experimantal Immunology, 162, 75-83. http://dx.doi.org/10.1111/j.1365-2249.2010.04226.x
|
[94]
|
Parmiani, G., Pilla, L., Maccalli, C. and Russo, V. (2011) Autologous versus Allogeneic Cell-Based Vaccines? Cancer Journal, 17, 331-336. http://dx.doi.org/10.1097/PPO.0b013e3182337a76
|
[95]
|
Fujiwara, S., Wada, H., Miyata, H., Kawada, J., Kawabata, R., Nishikawa, H., et al. (2012) Clinical Trial of the Intratumoral Administration of Labeled DC Combined with Systemic Chemotherapy for Esophageal Cancer. Journal of Immunotherapy, 35, 513-521. http://dx.doi.org/10.1097/CJI.0b013e3182619cb4
|
[96]
|
Longley, D.B. and Johnston, P.G. (2005) Molecular Mechanisms of Drug Resistance. Journal of Pathology, 205, 275-292. http://dx.doi.org/10.1002/path.1706
|
[97]
|
Rebucci, M. and Michiels, C. (2013) Molecular Aspects of Cancer Cell Resistance to Chemotherapy. Biochemical Pharmacology, 85, 1219-1226. http://dx.doi.org/10.1016/j.bcp.2013.02.017
|
[98]
|
Salehan, M.R. and Morse, H.R. (2013) DNA Damage Repair and Tolerance: A Role in Chemotherapeutic Drug Resistance. British Journal of Biomedical Science, 70, 31-40.
|
[99]
|
Sebens, S. and Schafer, H. (2012) The Tumor Stroma as Mediator of Drug Resistance—A Potential Target to Improve Cancer Therapy? Current Pharmaceutical Biotechnology, 13, 2259-2272. http://dx.doi.org/10.2174/138920112802501999
|
[100]
|
Gordon, R.R. and Nelson, P.S. (2012) Cellular Senescence and Cancer Chemotherapy Resistance. Drug Resistance Updates, 15, 123-131. http://dx.doi.org/10.1016/j.drup.2012.01.002
|
[101]
|
Wang, Z. and Chen, W. (2013) Emerging Roles of SIRT1 in Cancer Drug Resistance. Genes and Cancer, 4, 82-90. http://dx.doi.org/10.1177/1947601912473826
|
[102]
|
Ravindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., et al. (2014) A Stress-Induced Early Innate Response Causes Multidrug Tolerance in Melanoma. Oncogene, Published Online. http://www.ncbi.nlm.nih.gov/pubmed/25417704
|
[103]
|
Li, S., Kennedy, M., Payne, S., Kennedy, K., Seewaldt, V.L., Pizzo, S.V. and Bachelder, R.E. (2014) Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy. PLoS ONE, 9, e98021. http://dx.doi.org/10.1371/journal.pone.0098021
|
[104]
|
Naito, M., Aisu, N., Maki, K., Nakagawa, M., Yoshida, Y., Hoshino, S. and Yamashita, Y. (2014) A Case of Unresected Gastric Cancer That Maintained Long Tumor Dormancy by Use of Paclitaxel+S-1 Combination Therapy. Gan to Kagaku Ryoho, 41, 241-244.
|
[105]
|
Mitchell, T. and Turton, P. (2011) “Chemobrain”: Concentration and Memory Effects in People Receiving Chemotherapy—A Descriptive Phenomenological Study. European Journal of Cancer Care, 20, 539-548. http://dx.doi.org/10.1111/j.1365-2354.2011.01244.x
|
[106]
|
Areti, A., Yerra, V.G., Naidu, V. and Kumar, A. (2014) Oxidative Stress and Nerve Damage: Role in Chemotherapy Induced Peripheral Neuropathy. Redox Biology, 2, 289-295. http://dx.doi.org/10.1016/j.redox.2014.01.006
|
[107]
|
Anderson, B. and Sawyer, D.B. (2008) Predicting and Preventing the Cardiotoxicity of Cancer Therapy. Expert Review of Cardiovascular Therapy, 6, 1023-1033. http://dx.doi.org/10.1586/14779072.6.7.1023
|
[108]
|
Abid, S.H., Malhotra, V. and Perry, M.C. (2001) Radiation-Induced and Chemotherapy-Induced Pulmonary Injury. Current Opinion in Oncology, 13, 242-248. http://dx.doi.org/10.1097/00001622-200107000-00006
|
[109]
|
Andreyev, H.J. (2010) A Physiological Approach to Modernize the Management of Cancer Chemotherapy-Induced Gastrointestinal Toxicity. Current Opinion in Supportive and Palliative Care, 4, 19-25. http://dx.doi.org/10.1097/SPC.0b013e32833575cc
|
[110]
|
Al-Tweigeri, T., Nabholtz, J.M. and Mackey, J.R. (1996) Ocular Toxicity and Cancer Chemotherapy: A Review. Cancer, 78, 1359-1373. http://dx.doi.org/10.1002/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G
|
[111]
|
Kalialis, L.V., Drzewiecki, K.T. and Klyver, H. (2009) Spontaneous Regression of Metastases from Melanoma: Review of the Literature. Melanoma Research, 19, 275-282. http://dx.doi.org/10.1097/CMR.0b013e32832eabd5
|
[112]
|
Jessy, T. (2011) Immunity over Inability: The Spontaneous Regression of Cancer. Journal of Natural Science, Biology and Medicine, 2, 43-49. http://dx.doi.org/10.4103/0976-9668.82318
|
[113]
|
Papac, R.J. (1998) Spontaneous Regression of Cancer: Possible Mechanisms. In Vivo, 12, 571-578.
|
[114]
|
Lagova, N.D. (1978) Mechanism of Mammary Cancer Regression in Lactating Rats. Biulleten Eksperimentalnoi Biologii I Meditsiny (Moskva), 85, 582-585.
|
[115]
|
Buijs, M., Geschwind, J.F., Syed, L.H., Ganapathy-Kanniappan, S., Kunjithapatham, R., Wijlemans, J.W., et al. (2012) Spontaneous Tumor Regression in a Syngeneic Rat Model of Liver Cancer: Implications for Survival Studies. Journal of Vascular and Interventional Radiology, 23, 1685-1691. http://dx.doi.org/10.1016/j.jvir.2012.08.025
|
[116]
|
Chang, W.Y. (2000) Complete Spontaneous Regression of Cancer: Four Case Reports, Review of Literature, and Discussion of Possible Mechanisms Involved. Hawaii Medical Journal, 59, 379-387.
|
[117]
|
Bukhtoyarov, O.V. and Samarin, D.M. (2012) Psychogenic Carcinogenesis. In: Mohan, R., Ed., Advances in Cancer Management, InTech, Rijeka, 17-56.
|
[118]
|
Moser, R.P., Arndt, J., Han, P.K., Waters, E.A., Amsellem, M. and Hesse, B.W. (2014) Perceptions of Cancer as a Death Sentence: Prevalence and Consequences. Journal of Health Psychology, 19, 1518-1524. http://dx.doi.org/10.1177/1359105313494924
|
[119]
|
Bukhtoyarov, O.V. and Samarin, D.M. (2013) Psychogenic Activation Phenomenon of Specific Anti-Tumor Immunity in Cancer Patients. International Journal of Medicine and Medical Sciences, 5, 198-205.
|
[120]
|
Ikemi, Y., Nakagawa, S., Nagakawa, T. and Sugita, M. (1975) Psychosomatic Consideration on Cancer Patients Who Have Made a Narrow Escape from Death. Dynamic Psychiatry, 8, 77-91.
|
[121]
|
Niakan, B. (1998) A Mechanism of the Spontaneous Remission and Regression of Cancer. Cancer Biotherapy and Radiopharmaceuticals, 13, 209-210. http://dx.doi.org/10.1089/cbr.1998.13.209
|
[122]
|
MаcAdam, D. (2003) Spontaneous Regression: Cancer and the Immune System. Replica Books, New York, 164 p.
|
[123]
|
Zhong, H., Han, B., Tourkova, I.L., Lokshin, A., Rosenbloom, A., Shurin, M.R. and Shurin, G.V. (2007) Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth. Clinical Cancer Research, 13, 5455-5462. http://dx.doi.org/10.1158/1078-0432.CCR-07-0517
|
[124]
|
Bukhtoyarov, O.V. and Samarin, D.M. (2013) Psycho-Immunological Rehabilitation of Advanced Cancer Patients with Psychogenic Medical History. Journal of Medicine and Medical Sciences, 5, 489-502.
|